hiv/aids the epidemic in ane and e&e so what do we do now? paul de lay senior advisor on...
TRANSCRIPT
![Page 1: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/1.jpg)
HIV/AIDSHIV/AIDSThe Epidemic in The Epidemic in
ANE and E&EANE and E&ESo what do we do now?So what do we do now?
Paul De LayPaul De Lay
Senior Advisor on Senior Advisor on HIV/AIDSHIV/AIDS
Office of HIV/AIDSOffice of HIV/AIDS
![Page 2: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/2.jpg)
Factors that influence Factors that influence the spread of HIVthe spread of HIV
The VirusThe Virus The HostThe Host The Role of BehaviorThe Role of Behavior
![Page 3: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/3.jpg)
The VirusThe Virus
Time of introduction into a Time of introduction into a populationpopulation
HIV subtypesHIV subtypes Levels of viremiaLevels of viremia
![Page 4: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/4.jpg)
ASIA & OCEANIA
CAMBODIA
THAILAND
BURMA
PAKISTAN
LAOS
INDIA
VIETNAM
LAC
HAITI
HONDURAS
GUYANA
BRAZIL
BELIZE
DOMINICAN REP.
ARGENTINA
BARBADOS
JAMAICA
TRIN. & TOB.
0 10 20 30 40 50
% Seropositive
AFRICA
BOTSWANA
SOUTH AFRICA
LESOTHO
MALAWI
SWAZILAND
ZIMBABWE
ZAMBIA
NAMIBIA
RWANDA
BURUNDI
ETHIOPIA
KENYA
UGANDA
TANZANIA
COTE D'IVOIRE
CAR
LIBERIA
MOZAMBIQUE
BURKINA FASO
TOGO
NIGERIA
CHAD
CONGO
CAMEROON
GABON
BENIN
CONGO, (ZAIRE)
0 10 20 30 40 50
% Seropositive
HIV-Seroprevalence among Pregnant HIV-Seroprevalence among Pregnant women from Capital or Major Urban women from Capital or Major Urban
Centers in Selected CountriesCenters in Selected Countries
![Page 5: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/5.jpg)
The Host (Us)The Host (Us)
The presence of a sexually The presence of a sexually transmitted diseasetransmitted disease
The age of the personThe age of the person Immunologic characteristicsImmunologic characteristics Male circumcisionMale circumcision
![Page 6: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/6.jpg)
June 1998 UNAIDS/WHO Estimates of HIV Seroprevalence in
South/South-East Asian Countries
< 20% Circumcised > 80% Circumcised
Cambodia 2.40 Pakistan 0.09
Thailand 2.23 Philippines 0.06
Myanmar 1.79 Indonesia 0.05
India 0.82 Bangladesh 0.03
Nepal 0.24[From Halperin D, Bailey R. “Male Circumcision and HIV Infection: Ten Years and Counting,” Lancet 1999; 354: 1813-5]
![Page 7: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/7.jpg)
Elements of HIV/AIDS Elements of HIV/AIDS ProgramsPrograms
PreventionPrevention Blood safetyBlood safety Universal Universal
precautionsprecautions Sexual risk reductionSexual risk reduction Harm reductionHarm reduction Condom social Condom social
marketingmarketing STI managementSTI management Voluntary Voluntary
Counseling and Counseling and TestingTesting
Stigma reductionStigma reduction Preventing MTCTPreventing MTCT Surveillance and Surveillance and
M&EM&E
Care and MitigationCare and Mitigation Palliative carePalliative care Psychosocial supportPsychosocial support Improve nutritionImprove nutrition Effective Treatment of Effective Treatment of
Opportunistic InfectionsOpportunistic Infections Use of Highly Active Use of Highly Active
Anti-Retroviral Therapy Anti-Retroviral Therapy Orphans and Orphans and
Vulnerable ChildrenVulnerable Children Other mitigation Other mitigation
activitiesactivities
![Page 8: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/8.jpg)
Complex Epidemics In Complex Epidemics In Rapidly Changing Rapidly Changing
SocietiesSocietiesSerious localized fociSerious localized foci
Blood IDU MSM Hetero
Bangladesh X X X
Cambodia X X
India X X X X
Indonesia X X X X
Nepal X X X
Russia X X X
CAR X X X
![Page 9: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/9.jpg)
Comparison of average number of Comparison of average number of clients per sex worker versus % of clients per sex worker versus % of young men to utilized sex workersyoung men to utilized sex workers
0
0.5
1
1.5
2
2.5
3
3.5
4
0 10 20 30 40 50 60
% males using sex workers
Ave
rag
e #
of
CS
cli
ents
/day
Indonesia
Philippines
Cambodia
Thailand
![Page 10: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/10.jpg)
Behavior change Behavior change interventionsinterventions
IDU IDU Reduce drug use/harm reductionReduce drug use/harm reduction
MSMMSM Stigma, accessStigma, access
Commercial sex workers and Commercial sex workers and their clientstheir clients Stigma, accessStigma, access
![Page 11: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/11.jpg)
ImplicationsImplications
In South and South-East Asia, condom In South and South-East Asia, condom promotion and STI interventions for sex promotion and STI interventions for sex workers top priorityworkers top priority
In Central and Eastern Asia, Europe, In Central and Eastern Asia, Europe, LAC and North America, programs for LAC and North America, programs for injecting drug users, MSM and, to lesser injecting drug users, MSM and, to lesser extent sex workers, top priorityextent sex workers, top priority
![Page 12: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/12.jpg)
Providing antiretroviralsProviding antiretrovirals
Of the 40 million persons infected, Of the 40 million persons infected, about 6-7 million would qualify for ARV about 6-7 million would qualify for ARV RxRx
250,000 persons in developing world 250,000 persons in developing world are on combination ARVare on combination ARV
WHO has set a target of 3 million WHO has set a target of 3 million persons on ARV Rx by 2005persons on ARV Rx by 2005
Barcelona updateBarcelona update
![Page 13: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/13.jpg)
Should USAID be Should USAID be supporting ARV therapy supporting ARV therapy
in ANE and E&E countriesin ANE and E&E countries
Better health infrastructureBetter health infrastructure ?? Stronger private sector?? Stronger private sector ?Smaller numbers?Smaller numbers Drug production capacityDrug production capacity
![Page 14: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/14.jpg)
Preventing Mother-To-Child Preventing Mother-To-Child HIV Transmission (PMTCT)HIV Transmission (PMTCT)
Over 100 programs in 11 countriesOver 100 programs in 11 countriesIssues:Issues:
stigmastigma controversies over safe infant controversies over safe infant
feedingfeeding treatment of parentstreatment of parents
Will MTCT reduce stigma and Will MTCT reduce stigma and increase use of VCT, Rx????increase use of VCT, Rx????
![Page 15: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/15.jpg)
The Next Five YearsThe Next Five YearsBasic AssumptionsBasic Assumptions
Unlikely to have an effective vaccineUnlikely to have an effective vaccine Microbicide candidates will still be in Microbicide candidates will still be in
Phase III testingPhase III testing Continued growth of epidemic in some Continued growth of epidemic in some
settings in all regions-beware slow growthsettings in all regions-beware slow growth Deterioration/collapse of key social and Deterioration/collapse of key social and
economic sectors in hard hit countrieseconomic sectors in hard hit countries Massive orphan problemMassive orphan problem Increasing # PWAs needing ARV RxIncreasing # PWAs needing ARV Rx Increasing number of success stories at Increasing number of success stories at
national levelnational level
![Page 16: HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS](https://reader036.vdocument.in/reader036/viewer/2022081602/5513d7e355034646298b544e/html5/thumbnails/16.jpg)
The Next Five YearsThe Next Five Years
Prevention works! Still key to winning the war. Prevention works! Still key to winning the war. Increase care/treatmentIncrease care/treatment Synergy between strategy elementsSynergy between strategy elements Invest in human capacityInvest in human capacity Advances: e.g. microbicides, rapid TB Advances: e.g. microbicides, rapid TB
diagnosisdiagnosis Impact on health infrastructure and other Impact on health infrastructure and other
sectorssectors Improved coordinationImproved coordination